RTA 744

A substance being studied in the treatment of adult brain tumors. RTA 744 crosses the blood-brain barrier and blocks an enzyme needed for cancer growth. RTA 744 is a type of topoisomerase inhibitor. Also called topoisomerase II inhibitor RTA 744.

English dictionary of cancer terms . 2015.

Look at other dictionaries:

  • topoisomerase II inhibitor RTA 744 — A substance being studied in the treatment of adult brain tumors. Topoisomerase II inhibitor RTA 744 crosses the blood brain barrier and blocks an enzyme needed for cancer growth. It is a type of topoisomerase inhibitor. Also called RTA 744 …   English dictionary of cancer terms

  • San Bernardino County, California — County of San Bernardino   County   Seal …   Wikipedia

  • Akron, Ohio — Akron redirects here. For other uses, see Akron (disambiguation). City of Akron   City   …   Wikipedia

  • Metro systems by annual passenger rides — Cities with metro systems The …   Wikipedia

  • Captain Britain Corps — Publication information Publisher Marvel Comics First appearance Mighty World of Marvel #13 (1984) In story information …   Wikipedia

  • Brahmaputra — Yarlung Tsangpo, Dihang, Jamuna Oberlauf in Tibet DatenVorlage:Infobox Fluss …   Deutsch Wikipedia

  • Bigeard — Marcel Bigeard Marcel Bigeard Naissance 14 février 1916 Toul, France Origine  France Allégeance …   Wikipédia en Français

  • Cariciacum — Quierzy Quierzy Administration Pays France Région Picardie Département Aisne Arrondissement Laon Canton Coucy le Château Auffrique …   Wikipédia en Français

  • Carisiacum — Quierzy Quierzy Administration Pays France Région Picardie Département Aisne Arrondissement Laon Canton Coucy le Château Auffrique …   Wikipédia en Français

  • Charisagum — Quierzy Quierzy Administration Pays France Région Picardie Département Aisne Arrondissement Laon Canton Coucy le Château Auffrique …   Wikipédia en Français

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”

We are using cookies for the best presentation of our site. Continuing to use this site, you agree with this.